Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 4Completed 4Recruiting 3Not yet recruiting 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Thyroid Neoplasms 1Oropharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Neck Dissection × Clear all
NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
352 enrolled
Head & Neck

Thyroid Neoplasms

NCT03210103 2026-01-28

ORATOR2

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting
61 enrolled
Head & Neck

Head and Neck Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡